ACTA1 and chronic obstructive pulmonary disease: COPD rat models demonstrated that N-acetylcysteine significantly reduced α-SMA level, collagen volume fraction, wall thickness/bronchiole diameter, and wall area/total bronchiole area (MA%) in COPD rats.